TIAM2
INSM icon

Tru Independence Asset Management 2’s Insmed INSM Stock Holding History

Tru Independence Asset Management 2’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,811
Closed -$641K – 117
2021
Q1 		$641K Buy
+18,811
New +$719K 0.51% 51

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Tru Independence Asset Management 2's INSM Position: Q2 2021 in Review

Tru Independence Asset Management 2 sold out of Insmed (INSM) in Q2 2021, closing a stake of 18,811 shares — an estimated $641K sold.

Tru Independence Asset Management 2 first reported a position in INSM in Q1 2021 and held it in 1 quarter. The position peaked at $641K in Q1 2021. 203 funds tracked by Wall St. Rank hold INSM as of Q2 2021.

  • Tru Independence Asset Management 2 reported no remaining Insmed position as of Q2 2021 after selling out during the quarter.
  • Tru Independence Asset Management 2 sold 18,811 Insmed shares in Q2 2021, an estimated $641K.
  • Tru Independence Asset Management 2 first reported a position in Insmed in Q1 2021 and held it in 1 quarter.
  • Tru Independence Asset Management 2's Insmed position peaked at $641K in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Insmed as of Q2 2021.

Based on Tru Independence Asset Management 2's 13F filing for Q2 2021, filed 21 Jul 2021.